Molecular subtyping of BC utilizes estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2) status to divide the disease into four subtypes: luminal A, luminal B, triple negative, and HER2-positive (Table 1) 23. This evidence concerns the gene ERBB2 and breast cancer.